Unjha Formulations Q1 Results
- BSE: 531762
- NSE: -
- ISIN: INE576D01015
- Sector: Biotechnology & Drugs
BSE
22.55
-0.45 (-1.96%)
-0.45 (-1.96%)Volume1.54 K
Updated: Tue 10 Feb, 2026 | 15:28:52
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Unjha Formulations Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 3.24 | 2.73 | 18.84% | 3.25 | -0.37% |
| Depreciation/ Amortization | 0.03 | 0.03 | -7.14% | 0.02 | 29.41% |
| Operating Income | 0.37 | -0.36 | 0.00% | 0.70 | -46.70% |
| Net Income | 0.39 | -0.40 | 0.00% | 0.70 | -44.21% |
| Other Operating Expenses Total | 0.38 | 0.12 | 213.02% | 0.22 | 76.79% |
| Net Income Before Taxes | 0.39 | -0.29 | 0.00% | 0.70 | -44.21% |
| Total Revenue | 3.61 | 2.37 | 52.78% | 3.95 | -8.55% |
| Selling/ General/ Admin Expenses Total | 0.13 | 0.36 | -63.04% | 0.18 | -24.52% |
| Diluted Normalized EPS | 0.90 | -0.91 | 0.00% | 1.56 | -42.30% |